Welcome to LookChem.com Sign In|Join Free
  • or
Hefei TNJ chemical industry co.,ltdEnrofloxacin Hcl price//file1.lookchem.com/300w/synthetic/2022-02-06-01/8e6f2063-7bc1-4300-833c-7ee3bdfdb8f0.png
qq

Communicate with Supplier:

Ms. Sophia Zhang
Ms. Sophia Zhang: What can I do for you?

Enrofloxacin Hcl price CAS NO.112732-17-9

MSDS/COA Download

Min.Order Quantity:
0 Metric Ton
Purity:
99%
Port:
main ports in China
Payment Terms:
L/C,D/A,D/P,T/T,Other

Add to Inquiry Cart

Product Details

Keywords

  • Enrofloxacin Hcl
  • 112732-17-9
  • Enrofloxacin Hcl supplier

Quick Details

  • ProName: Enrofloxacin Hcl price
  • CasNo: 112732-17-9
  • Molecular Formula: C19H22FN3O3.ClH
  • Appearance: White or light yellow crystalline acic...
  • Application: Used as a beast with antibacterial dru...
  • DeliveryTime: within 7 days after confirm payment
  • PackAge: 25kg/drum or according to your require...
  • Port: main ports in China
  • ProductionCapacity: Metric Ton/Day
  • Purity: 99%
  • Storage: Storage: All products should be stored...
  • Transportation: by sea or by air
  • LimitNum: 0 Metric Ton

Superiority

1. basic information

enrofloxacin base ,93106-60-6
enrofloxacin hcl ,112732-17-9
quality standard :cpv2010 /usp/ep/bp
use:veterinary medicine

appearance: light-yellow or light-yellow orange crystalline powder

purity: 99% min

2.introduction

enrofloxacin is a broad spectrum bactericidal drugs, have special effects on mycoplasma. white on escherichia coli, klebsiella bacillus coli, pseudomonas aeruginosa, salmonella, deformation, haemophilus, kill, pasteurella, streptococcus hemolytic pap coli, s. aureus bacteria, such as have antiseptic effect.

3.specification

item

standard

result

appearance

light-yellow or light-yellow orange crystalline powder

light-yellow crystalline powder

melting range

between 221°c and 226°c

223.0°c~225.5°c

identification

meet the requirements

meet the requirements

fluoroquinolonic acid

not more than 0.2%

<0.2%

ciprofloxacin

not more than 1.0%

0.15%

loss on drying

not more than 3.0%

0.1%

residue on ignition

not more than 0.2%

0.04%

heavy metals

not more than 20ppm

<20ppm

assay(on the dried basis)

not less than 98.5%

99.1%

4.application

dogs and cats

the product is indicated in the treatment of bacterial infections of the alimentary, respiratory and urogenital tracts, skin, secondary wound infections and otitis externa where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice.

cattle

diseases of the respiratory and alimentary tract of bacterial or mycoplasmal origin (e.g. pasteurellosis, mycoplasmosis, coli-bacillosis, coli-septicaemia and salmonellosis) and secondary bacterial infections subsequent to viral conditions (e.g. viral pneumonia) where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice.

pigs

diseases of the respiratory and alimentary tract of bacterial or mycoplasmal origin (e.g. pasteurellosis, actinobacillosis, mycoplasmosis, coli-bacillosis, coli-septicaemia and salmonellosis) and mulifactorial diseases such as atrophic rhinitis and enzootic pneumonia, where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice.

Details

1. basic information

enrofloxacin base ,93106-60-6
enrofloxacin hcl ,112732-17-9
quality standard :cpv2010 /usp/ep/bp
use:veterinary medicine

appearance: light-yellow or light-yellow orange crystalline powder

purity: 99% min

2.introduction

enrofloxacin is a broad spectrum bactericidal drugs, have special effects on mycoplasma. white on escherichia coli, klebsiella bacillus coli, pseudomonas aeruginosa, salmonella, deformation, haemophilus, kill, pasteurella, streptococcus hemolytic pap coli, s. aureus bacteria, such as have antiseptic effect.

3.specification

item

standard

result

appearance

light-yellow or light-yellow orange crystalline powder

light-yellow crystalline powder

melting range

between 221°c and 226°c

223.0°c~225.5°c

identification

meet the requirements

meet the requirements

fluoroquinolonic acid

not more than 0.2%

<0.2%

ciprofloxacin

not more than 1.0%

0.15%

loss on drying

not more than 3.0%

0.1%

residue on ignition

not more than 0.2%

0.04%

heavy metals

not more than 20ppm

<20ppm

assay(on the dried basis)

not less than 98.5%

99.1%

4.application

dogs and cats

the product is indicated in the treatment of bacterial infections of the alimentary, respiratory and urogenital tracts, skin, secondary wound infections and otitis externa where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice.

cattle

diseases of the respiratory and alimentary tract of bacterial or mycoplasmal origin (e.g. pasteurellosis, mycoplasmosis, coli-bacillosis, coli-septicaemia and salmonellosis) and secondary bacterial infections subsequent to viral conditions (e.g. viral pneumonia) where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice.

pigs

diseases of the respiratory and alimentary tract of bacterial or mycoplasmal origin (e.g. pasteurellosis, actinobacillosis, mycoplasmosis, coli-bacillosis, coli-septicaemia and salmonellosis) and mulifactorial diseases such as atrophic rhinitis and enzootic pneumonia, where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)